Calls the half-trim itself the aggressive move: sell into the 100% bullish retail tape while the MACD bearish cross and the stalled rally confirm the reward/risk has collapsed to roughly 1:1 — selling now monetizes the stall rather than hoping it resolves higher.
Keeps the residual with the looser $695.66 line and stands ready to buy aggressively into a $665–700 reset or re-engage on a confirmed close above $742 — a two-sided, portfolio-level asymmetry rather than a simple hold.
Agrees the half-trim is the correct balanced decision but calls the Aggressive analyst's $695.66 stop too loose and the Conservative analyst's cut-to-zero too extreme — both the 19-message sentiment sample and the imminent golden cross are too thin to drive an extreme call.
Tightens the residual's protective line to a sustained daily close below the $713.19 swing low, and re-enters only in phases — a small starter near $700 or on a high-volume reclaim above $742 — rather than buying aggressively into either scenario.
Agrees the sell is correct but says it doesn't go far enough: a $695.66 stop is more than a full ATR away and can gap through on one bad open, so for most callers META should be cut to a quarter-weight or zero rather than half.
Wants any residual protected at the VWMA ($723.93) or at worst the $713.19 swing low, with re-entry only on a high-volume close above $742 or clear stabilization evidence in the $665–700 zone — "cash is a position."
Thesis: All three risk analysts, the trader's plan, and the research manager converge on reducing META, splitting only on degree. Nobody in the record advocates a full exit: the intact primary uptrend (price above rising 50 SMA $624.66 and 200 SMA $627.39, shrinking-volume pullback, RSI reset to 61.5) argues for keeping a residual with defined lines. But four dimensions decide the allocation at $728.08 and went unrebutted by the bull: earnings falling (operating income −8% YoY, EPS −13.4%, expenses +55%) while revenue accelerates; no valuation cushion (~46x trailing FCF on a declining trend, still ~31x even if capex normalizes); a tape that failed into the $735–742 shelf on a fresh MACD bearish crossover with only ~$4 of VWMA cushion; and a risk/reward that collapses to roughly 1:1 once the $713.19 stop is measured against ATR ($25.43).
Action: Trim META to roughly half of a standard/normal allocation — if full-weight, cut to ~0.5x; if establishing fresh, cap initial exposure at half of standard sizing. Do not add at $728.08. Rebuild toward normal weight only on (a) a high-volume close above $742 confirming the breakout, scaled in over 2–3 increments, or (b) a stabilized reset into the $665–700 zone with signs the FCF trend is stabilizing, using a stop below $665. Treat a sustained close below the VWMA at $723.93 as a signal to cut further, with $695.66 as the hard line. Re-underwrite on Q3 2026 operating income/margin stabilization, a visible peak in the capex/CIP trajectory, or buyback resumption — any of which would justify upgrading back toward Hold/Overweight.